Snoasis Medical is a leader in placental based products with 48 scientific and clinical publications including Randomized Controlled Trials (RCTs) published.
Stay tuned as we continue to update this section with the latest additions to the growing body of evidence demonstrating that BioXclude is the best option for your patients.
It pleases me to share new cool scientific research comparing amnion-chorion membrane (ACM) products BioXclude®, AlloGuide™ GF and AmnioExcite™ in a well-established bacterial inhibition assay that evaluates ability to prevent the growth of Streptococcus gordonii, a pathogenic strain of bacteria associated with periodontal disease.
I am pleased to share a new BioXclude article recently published in Clinical Advances in Periodontics.
New BioXclude Publication, Open Wound Approach for Horizontal Ridge Augmentation BioXclude + Initiation of Prospective Randomized Clinical Study to Confirm Observed Results
Clinical data challenging the concept that predictable and successful horizontal ridge augmentation requires primary closure when using BioXclude.
This spring we requested your best cases, and today I am both honored and excited to share with you our winner for the best case in the general dentistry and implantology category, Dr. Dean Licenblat.
NEW BioXclude Poster, Antimicrobial With & Without Nicotine Against Four Dental Pathogens |2020 Academy of Osseointegration
We are excited to share this poster by Yusuke Hamada, DDS, MSD presented at the Academy of Osseointegration Annual Meeting: Antimicrobial Effects of Dehydrated Human Amnion-Chorion Membranes Against Dental Pathogens With and Without the Effect of Nicotine: In Vitro.
I am pleased to share our second publication, appearing in the prestigious journal Scientific Reports (4.6 Impact Factor), documenting the antibacterial properties of our Purion® processed human deepithelialized amnion-chorion membrane (BioXclude®)
You already know BioXclude® is different and awesome, which is why you won’t be surprised to hear that its use in socket preservation is leading to incredible results! The healing at 3-4 days is unprecedented.
BioXclude “Kills” S. Gordonii w/ Histone H2A/H2B, Cathelicidin, Lactoferrin and Lysozyme - New Poster Presentation, Update from AAP
Hot News! I am pleased to share an exciting poster presentation on BioXclude® from the on-going annual American Academy of Periodontology meeting.
We requested your best cases, and today I am both honored and excited to share with you our winner for the best case in the oral & maxillofacial surgery category, Michael J. Hartman, DMD, MD.
Have You Had Negative Encounters With Exposed Membranes? Amazing Post-Operative Healing In Only 3-4 Days - BioXclude® - The New Standard In Patient-Centered Benefits
Antimicrobial properties are yet another reason why primary closure is not required for predictable, successful outcomes in many types of guided bone regeneration procedures.
Does Your Membrane Have Antimicrobial Properties? BioXclude® Prevents Proliferation Of Oral Pathogens In-Vitro - New Publication
In this study, ddACM (BioXclude) prevented growth of all three bacterial strains: A.a., S.m., and S.o., performing as well as Tetracycline in this essay.
Why is it reasonable to refer to BioXclude® dehydrated human deepithelialized amnion-chorion membrane (ddACM) as “Nature’s Duct Tape”?